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Abstract 
In mammals successful rearing imposes a cost on later reproductive fitness specifically on 
the mother creating the potential for parental conflict. Loss of function of three imprinted 
genes  in the dam result in deficits in maternal care suggesting that, like maternal nutrients, 
maternal care is a resource over which the parental genomes are in conflict. However, the 
induction of maternal care is a complex and highly regulated process. Unsurprisingly many 
gene disruptions, as well as adverse environmental exposures in pregnancy, result in 
maternal care deficits. Recent compelling evidence for a more purposeful imprinting 
phenomenon comes from studying the impact of two imprinted genes, Phlda2 and Peg3, 
expressed in the placenta on the mother’s behaviour. The explicit demonstration that 
imprinted genes expressed in the offspring influence maternal behaviour lends significant 
weight to the hypothesis that maternal care is a resource that has been manipulated by the 
paternal genome. 
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Genomic imprinting 
Genomic imprinting is the term used to describe an epigenetic process whereby the parental 
alleles are marked in the germline to be differentially expressed in the offspring [1]. In 
modern mammals, this remarkable process had resulted in more than 100 protein coding 
genes and numerous noncoding RNAs being expressed predominantly from a single 
parental allele. Some imprinted genes are tightly regulated and globally monoallelically 
expressed, some show tissue and/or temporal specificities in their imprinted expression 
while others are paternally or maternally expressed in different tissues through the 
differential use of imprinted promoters. The existence of imprinted genes was essentially 
predicted prior to their physical discovery through the recognition of a conflict between 
parent and offspring [2], in particular those imposed by pregnancy [3]. Pregnancy represents 
a unique and challenging dilemma for mammals as considerable and almost exclusively 
maternal resources are required to produce offspring but the mother must, at the same time, 
ensure her own survival for the production of future offspring. Resource allocation has 
traditionally referred to nutrient allocation both during pregnancy and postnatally (lactation) 
but the finding in 1998 that an imprinted gene, called Paternally expressed gene 1 (Peg1) 
influenced maternal behaviour [4] suggested that maternal care provision is another 
resource which can potentially be manipulated by the parental genomes. 
 
Maternal behaviour is broadly defined as “the pattern of a mother's behaviour that appears 
to enhance her offspring's survival and reproductive success” [5]. The capacity to respond in 
a maternal manner is present in most, but not all, female mammals. The natural process of 
transitioning from a nulliparous female to a mother culminates in the initiation of enhanced 
maternal care towards new born offspring. These changes irreversibly alter the new 
mother’s motivational and behavioural repertoire driving an increased interest in sensory 
modalities associated with young. In humans, a failure to make the appropriate transition 
into motherhood can have lasting effects upon maternal health in the weeks, months and 
years after birth. Unsurprisingly, early social experiences gained through the relationship 
between the new mother and her offspring also significantly affects the developmental 
trajectory of her offspring [6; 7]. These early life interactions are associated with fundamental 
changes in the brain and behaviour that persist right through into adulthood.  Therefore 
understanding how maternal responses are primed prenatally and further stimulated from 
birth is  important not only for maternal mental health, but also for the health of future 
generations.  
 
Over the past two decades, there has been considerable progress in the foundational 
aspects of mammalian reproduction, including the processes involved in parturition, lactation, 
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behaviour and stress response. These discoveries have predominately been made in 
rodents. While rodents do not recapitulate all the sophisticated aspects of humans, mice and 
rats have been used as a model system to study maternal behaviour because they display 
behaviours that are predictable and testable, making them the ideal choice of animal model. 
Mice, and more recently rats, are also genetically modifiable allowing functional assessment 
of specific genes and, with conditional models, the function of specific genes with a spatial 
and/or temporal focus. Rodents give birth to relative immature young (altricial) with limited 
mobility, incapable of fending for themselves or maintaining their own body temperature. 
Consequently, the new mother must exhibit maternal behaviour at parturition to ensure their 
immediate survival. While both virgin females and males can respond to pups, both require 
several days of exposure to the pups before parental behaviours emerge [8].  
 
Maternal behaviours can be categorised as direct and pup-orientated or indirect and non-
pup orientated. Pup oriented behaviours are displayed as discrete acts of maternal care 
present from parturition. These include retrieving, grouping, crouching over pups to 
encourage suckling, and licking/grooming each individual pup to stimulate urination and 
heighten sensory stimuli developed only through nursing contact  [9]. Non-pup orientated 
behaviours encompass everything from finding and remembering food stores and water 
sources, identifying danger zones to building nests [9]. Nests, even if already built, are re-
constructed in a more elaborate and functional way for the young, to provide protection and 
warmth [10]. Late in pregnancy the female’s aggressive behaviour increases, important for 
defending resources [11]. Postpartum dams show heightened aggression towards intruders 
stimulated by the presence of the suckling pups, and reduced anxiety thought to be 
important for pup focused behaviour [12]. Pregnant females have increased appetite 
throughout pregnancy to support the developing fetus and to generate surplus energy stores  
(fat) for lactation with further increases in feeding and drinking postpartum [13]. Alterations in 
behaviour cannot come at the cost of maternal wellbeing. Postpartum the dam must 
continue to maintain her wellbeing through self-grooming, enhanced feeding and drinking to 
ensure survival of the litter and her future reproductive health. Taken together these 
behaviours are necessary to maximise the level of care and fitness she can bestow upon 
both herself and her young.  
 
Hormones and maternal behaviour 
Maternal care is primed in pregnancy through the direct action of hormones on the maternal 
brain, both those produced by the mother and also those that originate from the fetally-
derived placenta [8; 13; 14]. A number of hormones are produced by the maternal brain and 
function locally in the induction and maintenance of maternal care including prolactin [15; 
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16], serotonin [17], dopamine [18; 19; 20], oxytocin [21; 22; 23] and vasopressin [24; 25]. 
However, initial external stimuli are required to initiate the cascade of changes that occur to 
the maternal brain. In mice, prolactin secretion from the pituitary is initially stimulated by 
mating [26] and then secreted in surges in the afternoon and night until mid-gestation [14; 
27]. Prolactin has been shown to suppress the stress response in part through inhibiting the 
hypothalamic-pituitary-adrenal axis [28; 29], to induce changes in activity of oxytocin 
neurons [30], to stimulate neurogenesis [26], to suppresses ovulation and to regulate its own 
secretion [31]. At mid gestation, prolactin secretion is suppressed and superseded by the 
placental lactogens (Prls) which are lactogenic hormones related to prolactin but produced 
by the fetally-derived placenta. Prls predominate for the rest of pregnancy until, the night 
before parturition, prolactin secretion again surges in response to progesterone withdrawal 
[14; 27]. Prolactin stimulates maternal care [15; 16] and prolactin action in the medial 
preoptic area is necessary for postpartum maternal nursing behaviour and maternal 
neurogenesis [26]  while low levels of prolactin are associated with increased postpartum 
anxiety and decreased pup retrieval, alongside a reduction in pregnancy-induced 
neurogenesis [32]. Although the data is less clear, prolactin may also influence maternal 
neurogenesis in the sub granular zone of the hippocampus, important in learning and 
memory [33; 34]. Prolactin likely functions entirely via the prolactin receptor (Prlr) as loss of 
function of this receptor in nulliparous females, either homozygously or heterozygously, 
results in a defect in foster pup–induced maternal behaviour [35] and pregnant Prlr-/+ 
(heterozygous) dams display a 50% reduction in forebrain neurogenesis in the 
subventricular zone [26]. The fact that animals with a disrupted prolactin gene still exhibit 
some maternal behaviour [36], combined with the knowledge that Prl3d1 (PL-I) and Prl3b1 
(PL-II) are known to bind and activate the Prlr receptor [37] suggests that these Prls 
contribute to the induction of maternal care, although this has only been shown indirectly 
through the direct infusion of placental lactogen into the medial preoptic area of nulliparous 
rats [38].  
 
Lactogenic hormones are not solely responsible for initiating changes in the maternal brain. 
Steroid hormones (progesterone and oestradiol) produced primarily from the ovary diffuse 
across the blood brain barrier to act directly on the maternal brain [14]. Progesterone 
steadily increases during the pregnancy priming the female brain to respond to an acute 
increase in oestradiol that occurs at parturition while a fall in progesterone secretion at the 
end of pregnancy synchronises the onset of maternal behaviour with parturition [14; 39; 40]. 
Steroid hormones are produced from the ovary partly controlled by lactogenic hormones [40] 
but, while the placenta expresses some stereogenic enzymes, it does not appear to play a 
role in de novo steroid synthesis, at least in rodents [41]. Similarly, the placenta expresses 
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components of the serotonin, dopamine, oxytocin and vasopressin synthesis pathways but 
expressed at such low levels [42] that their site of action, if any, is likely to be fetal rather 
than maternal, as shown for serotonin [43]. The mouse placenta manufactures other protein 
hormones including secretin and galanin at more functionally convincing levels [44; 45].  
Secretin is required for hippocampal synaptic plasticity and secretin receptor mutant mice 
display abnormal social and cognitive behaviours [46; 47] while galanin-expressing neurons 
in the maternal hypothalamus are important for maternal behaviour with activation inducing 
pup grooming in virgin females and ablation of these neurons resulted in postpartum 
females attacking rather than caring for pups [45]. 
 
The complexity of changes to the maternal brain both during pregnancy and postpartum are 
such that it is not surprising that a vast number of genetic modification to the mother result in 
deficits in maternal behaviour. Indeed, when we surveyed the literature on genetic mutations 
leading to alterations in maternal behaviour, we found 64 examples reporting a deficit in 
maternal care and none that enhanced this behaviour [42]. The caveat is, of course, that it is 
much easier to spot a deficit in maternal care, particularly when there is reduced pup 
survival, than it is to detect improved maternal care. However, the potential for hormones 
manufactured by the placenta to influence the programming of the maternal brain in 
pregnancy suggests that placental endocrine changes driven by genetic alterations may also 
impact maternal behaviour, as now demonstrated for the first time by our lab [42].  
 
Disruptions of imprinted genes in the dam resulting in maternal care deficits 
1) Paternally expressed gene 1 (Peg1) 
Peg1 (aka Mest) was the first imprinted gene linked to maternal care in mice [4]. Peg1 was 
initially identified as an imprinted gene through subtractive hybridization between cDNAs 
from normal and parthenogenetic embryos, and found to map to the proximal region of 
mouse chromosome 6 [48]. The maternal promoter and part of exon 1 acquire DNA 
methylation during oocyte maturation [49] which is present in fetal tissues [50]. Peg1 is a 
member of the divergent α-β hydrolase protein family where 8 β-sheets are connected by α-
helices in the core of the protein [51]. During fetal development Peg1 is predominantly 
expressed in mesodermal tissues including heart, lung, cartilage, skeletal muscle and 
tongue, and also within the remnants of Rathke’s pouch, the amygdala, ventral hippocampus, 
main and accessory olfactory bulbs, cortex, dorsal hippocampus and striatum and the 
choroid plexus [4; 48]. Expression in the developing mouse midbrain overlaps with 
mesodiencephalic dopaminergic neurons before becoming restricted to part of the 
substantia nigra in adults [52].  
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Loss-of-function of Peg1 (paternal inheritance of the targeted allele) was found to result in a 
~15% proportionate growth restriction of the fetus and placenta at E18.5 when studied on 
the 129Sv strain background [4]. In this study, less than 50% of Peg1 mutants survived to 
adulthood and those that survived remain small with no evidence for catch-up growth. When 
Peg1 mutant females (paternal inheritance of targeted allele) were mated with wild type 
males, they underwent a normal first pregnancy (although this was not assessed in great 
detail) and delivered at term. However, Peg1 mutant dams frequently failed to remove 
extraembryonic membranes, eat the placenta or nurse their pups and nearly 90% of 
newborn died shortly after birth. In a pup retrieval task, mutant dams were found to sniff their 
pups indicating an intact olfactory response but did not retrieve them, and were disinterested 
in nest building. Neonates cross fostered to wild type foster mothers survived attributing the 
deficit to mutant dam rather than her offspring.  
 
2) Paternally expressed gene 3 (Peg3) 
Peg3 was the second imprinted gene linked to maternal care in mice [53]. Peg3 was 
identified with Peg1 [48] and in a second screen for novel imprinted genes and maps to the 
proximal mouse chromosome 7 [54]. Like Peg1, the maternal promoter region of Peg3 
inherits a DNA methylation mark from the oocyte [49]. Peg3 encodes a Kruppel C2H2-type 
zinc finger protein [54] which function to repress gene transcription [55; 56; 57]. Expression 
is predominantly from the paternal allele although maternal allele expression has been 
reported in the adult brain [58]. During fetal development Peg3 expression overlaps 
substantially with Peg1 [4; 53]. 
 
Loss-of-function of Peg3 (paternal inheritance of the targeted allele) results in fetal and 
placental growth restriction [53; 57; 59]. Mice are born small and remained small framed but 
deposit excess fat despite consuming less food [60]. Adult male and female mutant mice 
display altered behaviour with males failing to respond normally to sexually receptive 
females [61] and females exhibiting deficits in classic tests of maternal behaviours in their 
first pregnancy [53]. Peg3 mutant dams sniff their pups in the pup retrieval task but fail to 
return them to the nest in a timely manner, are slow to crouch over them and are poor nest 
builders. These original studies were made on the 129Sv stain background but despite 
naturally occurring differences in maternal behaviour [62], poor quality maternal care was 
also apparent when this same modification was examined on a C57BL/6J strain background 
[63], although not with a different modification [59]. When presented with wild type pups, 
parturient and nonparturient multiparous dams as well as virgin females all show impaired 
maternal behaviour [63],  again attributing the deficit to mutant female. These deficits may in 
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part be explained by a reduction in oxytocin-positive neurons in the hypothalamus compared 
to wild-type females [53; 63].   
 
3) Type 3 deiodinase (Dio3) 
Loss-of-function of Dio3 (paternal inheritance of the targeted allele) has more recently been 
linked to a deficit in maternal care [64]. Dio3 was identified as an imprinted gene in part due 
to its proximity to an imprinted gene cluster on chromosome 12 spanning Dlk1 and Gtl2 [65; 
66; 67]. Preferential allelic expression of Dio3 from the paternal allele occurs in most but not 
all fetal tissues [68] and the promoter lacks direct DNA methylation [66]. During development 
Dio3 is expressed in the fetal brain, eye, palate, tongue, skeletal muscle around the digits, 
mesenchyme of the frontal region, upper lip, and lower jaw, liver, gut mesentery, testes and 
in the labyrinthine trophoblast of the placenta. Dio3 is highly expressed in mature brain [65] 
where expression is reportedly biallelic [68]. 
 
Dio3 encodes an enzyme which inactivates the hormones thyroxine and 
3,5,3′‐triiodothyronine [69]. Dio3‐deficiency leads to brain thyroid hormone excess. Female 
mice show normal social interest in unfamiliar female mice outside their home cage but in 
their home cage they are aggressive towards unfamiliar females [64]. Dio3 mutant dams 
make flatter nests and show a deficiency in pup retrieval in their first but not their second 
pregnancy. They spend less time interacting with their pups and there is a high rate of pup 
mortality. Dio3 mutant females also show a mild olfactory impairment. How much of this 
behaviour is really specific to pregnancy is unclear as non-pregnant females exhibit 
increased activity and decreased anxiety/depression-like behaviour [64] alongside many 
other significant impairments [70]. 
 
Given the extensive and complex changes that occur in the maternal brain during pregnancy 
and postpartum [14; 71], it is perhaps not surprising that the genetic disruption of a number 
of imprinted genes in the dam result in deficits in maternal behaviour. A number of other 
imprinted genes are required for the normal function of the postnatal brain [72] and may also 
be important for maternal care. However, any finding based on global targeted deletions 
must be interpreted cautiously as loss-of-function of essential genes will have a catastrophic 
impact on many aspects of physiology and behaviour. Determining how these findings are to 
studies on imprinting will require both dose- and brain-specific manipulations.  
 
Postnatal influence of imprinted genes expressed in the offspring on maternal care. 
The presence of pups is clearly important for the manifestation of maternal behaviour and 
any mutation impacting pup characteristics has the potential to result in a secondary effect 
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on maternal behaviour. From birth pups begin communicating to their mothers using clicks 
and whistles. These ultrasonic vocalizations (USVs) increase in intensity and frequency 
when pups are separated from their mothers - hence the alternative and more forlorn term - 
“whistles of loneliness”   [73]. USVs are known to induce maternal behaviours such as nest 
building, pup retrieval and nursing [74; 75; 76; 77]. Loss of several genes within the 
Ubiquitin-protein ligase E3A (Ube3a) region [78] increase pup USVs while increased 
expression of Ube3a impairs these vocal communications [79]. Stimulation of dams by the 
act of suckling (but not lactation per se) initiates and maintains maternal aggression 
postpartum by stimulating oxytocin release from the maternal hypothalamus [80; 81]. Loss of 
function MAGE Family Member L2 (Magel2) [82], Peg3 [83] and Growth factor receptor-
bound substrate 10 (Grb10) [84] have all been reported to impact the ability of the pups to 
suckle with the potential of impacting maternal aggression. Even the pup’s ability to maintain 
their own body temperature could influence maternal behaviour requiring increased maternal 
'crouching', elevating demand on maternal resources. Several imprinted genes have been 
reported to play a role regulating brown adipogenesis impacting thermogenesis (body 
warmth) including Delta Like Non-Canonical Notch Ligand 1 (Dlk1)-Dio3 domain [85], cyclin 
dependent kinase inhibitor 1C (Cdkn1c) [86] and G protein alpha-subunit (Gnas) [87]. 
However, the effect of altered neonatal thermogenesis on wildtype maternal behaviour in the 
context of these models has yet to be explored. 
 
Prenatal influence of imprinted genes expressed in the offspring on maternal care. 
The placenta is predicted to play a role in programming maternal care through the 
production of hormones directly or indirectly implicated in maternal behaviour, although until 
recently this has never been formally demonstrated in a physiologically relevant model. The 
mouse placenta is grossly composed of three histologically distinct regions: the labyrinth 
where nutrient exchange takes place, the junctional zone which is a major endocrine 
compartment and the decidua which is the maternally derived component [88]. Seven 
distinct placental lineages express hormones including five trophoblast giant cell subtypes in 
close proximity to the maternal circulation, and the spongiotrophoblast and glycogen cell 
lineages located within the junctional zone [89; 90; 91; 92]. Of these, the spongiotrophoblast 
is the most substantial lineage in the mature mouse placenta [93]. Endocrine lineages 
expresses Prls [89; 90] and pregnancy specific glycoproteins (Psgs), a 17 member 
multigene gene family that modulate the maternal immune system and remodel vasculature 
[94]. Several maternally expressed imprinted genes have been shown to regulate these 
lineages [95] including Pleckstrin homology-like domain family A member 2 (Phlda2) [96] 
and Peg3 (in press). 
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Pleckstrin homology-like domain family A member 2 (Phlda2)  
Phlda2 is expressed primarily from the maternal allele only in extraembryonic structures with 
maternal bias or biallelic expression in the embryo and adult [97]. Phlda2 is expressed in the 
ectoplacental cone where the progenitors of many cell types of the mature placenta reside, 
and in the extraembryonic membranes (the visceral endoderm of the yolk sac) [97; 98]. 
From E10.5 Phlda2 expression is restricted to type I syncitiotrophoblast and, at a lower level, 
type II syncitiotrophoblast cells in the labyrinth zone, and declines in expression from E14.5.  
 
Studies from the Tycko laboratory and our research group defined a key role for Phlda2 in 
the development of the placenta [96; 99; 100; 101; 102]. Loss-of-function (maternal 
inheritance of targeted allele) resulted in placental overgrowth with a substantial increase in 
placental glycogen but with a negative impact on late fetal growth [96; 99]. Overexpression 
of Phlda2 also resulted in fetal growth restriction which we demonstrated first using at a 
transgenic mouse model in which Phlda2 was overexpressed at four-fold the normal level 
from a bacterial artificial chromosome (BAC) transgene [100]. Overexpression at both four-
fold and two-fold the normal level resulted in a similar degree of growth restriction of both the 
fetus and the placenta [96; 100; 101; 102]. Further assessment of the placental phenotype in 
the single copy line, effectively modelling loss of imprinting of Phlda2 (two-fold expression), 
identified the specific reduction of only one placental lineage, the spongiotrophoblast [96; 
101; 102]. We showed that Phlda2 suppresses the proliferation of the spongiotrophoblast 
from as early at E10.5 resulting in a 50% loss of this lineage by E14.5. Making use of the 
Phlda2 deletion allele, we were able to show that loss of Phlda2 resulted in a substantial 
increase in the contribution of the spongiotrophoblast lineage to the mature mouse placenta 
[96]. This work identified Phlda2 as a negative rheostat controlling the ultimate contribution 
of the spongiotrophoblast lineage to the mature mouse placenta. Given the expression of 
placental hormones from the spongiotrophoblast, this implied that Phlda2 indirectly regulates 
a vast array of placental hormones, further supported by RNA expression analysis that 
identified the spongiotrophoblast transcriptome [96]. Specifically, Phlda2 regulates the 
expression of a number of placental lactogens including Prl3b1, known to bind the prolactin 
receptor [37]. Together, this led us to hypothesise that the expression of imprinted genes in 
the placenta might influence maternal adaptations to pregnancy via placental hormones [95]. 
Given the known function of prolactin and the prolactin receptor in maternal care, we further 
hypothesised that placental Phlda2 might also influence maternal behaviour, which we 
tested by exposing wild type females to different offspring Phlda2 gene doses [42].   
 
A key aspect to this study was the maintenance of the dams genetically wild type status in 
order to isolate the function of Phlda2 in the offspring, achieved through recipient transfer of 
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embryos from genetically modified parents into wild type recipients (a mouse version of IVF). 
Wild type female mice exposed to offspring with three different doses of Phlda2 – either two 
active alleles (loss-of-imprint), one active allele (normal imprint) or no active allele (loss of 
maternal allele) – showed alterations in their hypothalamic and hippocampal transcriptomes 
during pregnancy, regions important for maternal-care behaviour. Each group showed 
distinct changes that included alterations in G protein-coupled receptors (GPCR) pathways 
through which neuropeptides and hormones mediate their action, olfactory transduction 
pathways important for maternal care [14; 103; 104] and the gonadotropin-releasing 
hormone signalling pathway, implicated in maternal care and known to respond to prolactin 
[105; 106]. In contrast to our prediction that increased placental hormone would translate to 
"better mothers", in the pup retrieval task dams exposed to higher levels of placental 
hormones in pregnancy (loss of Phlda2 expression) took significantly longer to retrieve their 
first pups than either fully wild type dams or those exposed to the lower dose of hormones 
(loss of Phlda2 imprint). Similarly, in the nest building task the dams we predicted would 
better at this task performed very poorly, with only one dam building a nest and putting her 
pups inside the nest. In stark contrast, the dams we predicted would be “worse mothers” 
(exposed to less hormones) actually performed better even than the fully wild type controls 
in nest building. However, in an undisturbed situation, all dams were able to effectively make 
nests and gather their pups within the nest. Pups gained weight appropriately arguing 
against a deficit in lactation and vocalisation (USVs) were normal when pups were 
separated from their mothers. A further exploration of dams’ behaviour in the disturbed 
situation (nest building task) revealed that dams exposed to higher levels of placental 
hormones in pregnancy were prioritising caring for their pups (licking and grooming) and 
themselves (self-grooming, feeding) over the nest building. As a final test, we asked whether 
dams exposed in utero to higher levels of placental hormones maintained their enhanced 
nurturing behaviour when presented with wild type pups from birth. These exposed dams 
similarly displayed enhanced nurturing towards the wild type fostered pups despite a 
considerable disruption imposed by the fostering process, supporting our original hypothesis 
that the priming of maternal care occurred prenatally. Overall the changes in maternal 
behaviour we observed were subtle and did not have a negative impact on either maternal 
or pup welfare, at least in the short term evidenced by appropriate pup weight gain. However, 
we do not know what the longer term consequence will be either for the dams in their 
second pregnancy, not for the offspring exposed to less optimal maternal care. Nor have we 
explored the neural changes or identified the specific placental hormone(s) mediating the 
relationship between the placenta and the maternal brain. Given the requirement for two 
copies of a functional prolactin receptor gene in maternal care [26; 35], and the knowledge 
that Prl3b1 binds this receptor [37], this seems a promising avenue to explore. Irrespective 
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of the gaps still remaining in our knowledge, this work firstly demonstrates the importance of 
optimal placental function in maternal care, at least in rodents, and highlights a new role for 
genomic imprinting in influencing maternal care giving before the offspring are born. 
 
Peg3 
As has already been discussed, loss-of-function of Peg3 in adult female mice negatively 
affects their maternal behaviour. Peg3 is expressed in both the developing fetus and in the 
placenta in the junctional zone and trophoblast giant cells [107]. Microarray studies on 
placental gene expression in response to loss of Peg3 suggested an impact on placental 
hormones [57; 108].  Together with our data on Phlda2, this led us to speculate that 
placental Peg3 may also function prenatally to influence maternal behaviour, potentially in 
an antagonistic manner to Phlda2. To test this hypothesis, we generated females carrying 
litters of all Peg3 mutant pups, this time by natural mating of wild type dams with males 
homozygous for the Peg3 targeted allele [109]. We observed very subtle changes in 
maternal novelty reactivity during pregnancy but no significant alterations in gene expression 
in the prenatal hypothalamus or hippocampus, at least at E16.5.  After birth, dams exposed 
to Peg3 mutant pups were slower to retrieve but showed no differences in nest building or 
the care of their pups during the nest building task. However, during the elevated zero maze 
task, which measures anxiety, the exposed dams showed evidence of increased anxiety. 
When we measured USVs, we found that the Peg3 mutant pups displayed fewer calls. 
Together, these data suggest that Peg3 predominantly influences maternal care in the post-
natal period through influencing direct communication to the mother. A major caveat to this 
conclusion is that we did not undertake a cross fostering experiment to isolate the pre- and 
post-natal influence of Peg3. A further caveat is our recent finding of a sexually dimorphic 
placental endocrine phenotype in Peg3 mutant mice (Tunster, in press). Loss of function of 
Peg3 results in a substantial loss of both the spongiotrophoblast and the glycogen cell 
lineage in male placenta, with female placenta showing an attenuated phenotype. 
Furthermore, when we examined the expression of placental hormones, female placenta 
showed very few alterations and some placental hormones were actually expressed at 
higher levels, despite the loss of spongiotrophoblast cells expressing these hormones. This 
finding is explained through a second sexually dimorphic function of Peg3 as a 
transcriptional repressor of some placental hormone genes [57]. Effectively, loss of Peg3 
results in fewer endocrine cells expressing higher levels of a subset of hormones both 
positively and negatively regulating the production of placental hormones with different 
consequences for male and female placenta. This new observation adds a further layer of 
complexity to our interpretation of the maternal behavioural changes in response to loss of 
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offspring Peg3. Since mouse litters are composed of both male and female foetuses, the 
presence of female placenta may “rescue” deficits in the mutant male placenta. 
 
Overall, these experiments highlight the bidirectional relationship between the mother and 
her offspring. Phlda2, which has been silenced by the paternal genome, functions normally 
to repress the production of placental hormones whereas Peg3, silenced by the maternal 
germline, functions to promote the production of placental hormones, and is also required for 
pups to effectively communicate to their mothers. During the evolution of mammals, 
paternalisation of Phlda2 may have boosted maternal care via the increased production of 
placental hormones whereas maternalisation of Peg3 may have decreased maternal care by 
decreasing the production of placental hormone and decreasing the vocal demands from the 
pup. Phlda2 is not imprinted in marsupials [110] but it is not known when, during the 
evolution of mammals, Peg3 acquired an imprinted status [111]. Nonetheless, this pre- and 
post-natal sequence of events suggests a continual and subtle rebalancing of maternal care 
allocation in mammals through the action of imprinted genes. Moreover, based on their 
function in regulating placental endocrine lineages [95], we predict that a number of other 
imprinted genes will similarly influence maternal care giving. 
 
Relevance to humans 
Studies on the function of imprinted genes in instructing maternal behaviour have been 
performed solely in mice. However, there is indirect data to suggest that these genes may 
have some similar functions in other mammals including humans. Higher placental 
expression of PHLDA2 has been reported in association with low birth weight in a number of 
studies [112]. Traditionally, infants are classified as low birth weight if born weighing less 
than 2.5 kg at any gestational age (United Nations Children’s Fund and World Health 
Organisation 2004). Low birth weight can be a consequence of a premature birth or fetal 
growth restriction where the baby has not reached its genetic growth potential, or both 
factors. Mice with two-fold expression of Phlda2, similar to the level reported in affected 
human pregnancies, display a slowdown in fetal growth late in gestation and are born low 
birth weight supporting a causal role for elevated PHLDA2 in driving fetal growth restriction 
and consequent low birth weight in human pregnancies. The inverse correlation between 
placental PHLDA2 expression and maternal serum levels of human placental lactogen [113] 
further suggests that PHLDA2 negatively regulates the production of placental hormones in 
humans and well as mice. Although there are substantial differences in the placental 
structure between man and mouse, and also in the type and function of placental hormones 
[114], this suggests the possibility that PHLDA2 may have a role in the induction of maternal 
care in human pregnancies. Little is known about the quality of care mothers provide to their 
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low birth weight newborn, and any observations are likely confounded by multiple factors 
surrounding the birth. However, while maternal care and maternal depression are two very 
different facets of pregnancy, depression could be a manifestation of miss programmed 
maternal behaviour in pregnancy. Both preterm birth and low birth weight are more common 
in pregnancies where mothers report depressive symptoms [115] and mothers of preterm 
birth and low birth infants are more likely to suffer postpartum depression [116]. In our study 
of placental gene expression in relation to prenatal clinically diagnosed depression, we did 
not find any association with PHLDA2 expression levels in the placenta [117]. However, this 
was a small number of women and we cannot formally exclude a role for placental PHLDA2 
in maternal mood disorders or postnatal care provision. In this same study we did find 
markedly reduced expression of PEG3 in both the placenta from pregnancies where women 
were clinically diagnosed with depression and also those pregnancies where women self-
reported depressive symptoms in pregnancy. This association was only apparent in the 
placenta from boys exposed to depression and not girls. Given our finding of a sexually 
dimorphic response of the mouse placenta to loss of Peg3 function (Tunster, in press), this 
lends support to a causal role for reduced Peg3 contributing to depression in human 
pregnancies. While we did not observe indicators of depressive symptoms in our Peg3 
mouse model, we did not use extensive tests for depression due to the pregnant status of 
the dams but dams were more anxious postpartum. Depression and anxiety are comorbid in 
human pregnancies and further work will be is essential to distinguish between the prenatal 
impact of placental dysfunction and the postnatal impact of reduced communication in this 
model.  
 
In summary, imprinted genes function in many aspects of development and behaviour but 
the often the catastrophic impact of loss of function can preclude a meaningful interpretation 
of the function of the imprint. Demonstrating that imprinted genes expressed in the offspring 
can influence maternal behaviour [42; 109], and more critically, boost the quality of maternal 
care, lends much greater weight to the idea that maternal care provision is a resource which 
is manipulated by the parental genomes. 
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Highlights 
 
 
 
 Many gene deletions in the dam, including the imprinted genes Peg1, Peg3 and 
Dio3, result in maternal care deficits.  
 Deletion of the offspring’s maternally-expressed Phlda2 enlarges a placental 
endocrine lineage boosting maternal care 
 Paternally-expressed Peg3 functions antagonistically to Phlda2 in the fetally-
derived placenta 
 Disruption of Peg3 also limits pup communication (USVs) exposing dams to a 
two-hit penalty. 
 Maternal care is a resource influenced by both parental genomes carried by the 
offspring 
 
 
 
